Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.
Not Applicable
Completed
- Conditions
- Drug UseQuality of Life
- Interventions
- Procedure: STOPP/START criteria
- Registration Number
- NCT03393299
- Lead Sponsor
- Lille Catholic University
- Brief Summary
Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
- Patient with more than 75 years old
- Hospitalized in geriatrics short-stay
- Patient with a written informed consent
- Patient with a social security scheme
Exclusion Criteria
- Severe dementia
- Not able to respond to SF-12
- Disease at final stage
- Patient under legal protection (maintenance of justice, tutelage, legal guardianship)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description STOPP/START STOPP/START criteria Use of STOPP/START criteria during medication reconciliation
- Primary Outcome Measures
Name Time Method SF-12 Quality of life scale at inclusion and at 2 months The evolution of the hospitalised elderly people's quality of life at 2 months will be measured by the SF-12 scale.
- Secondary Outcome Measures
Name Time Method Number of falls at 2 months The number of falls during the two months following the inclusion will be collected for each patient.
Proportion of patients rehospitalized at 2 months The proportion of patients that have been rehospitalized (unscheduled hospitalization) during the two months following inclusion will be measured.
Mortality at 2 months The mortality during the two months following inclusion will be measured.
Trial Locations
- Locations (1)
Hôpital La Porte Verte
🇫🇷Versailles, France